U. Kunzendorf et al., SUPPRESSION OF CELL-MEDIATED AND HUMORAL IMMUNE-RESPONSES BY AN INTERLEUKIN-2-IMMUNOGLOBULIN FUSION PROTEIN IN MICE, The Journal of clinical investigation, 97(5), 1996, pp. 1204-1210
Interleukin-2 (IL-2) plays a pivotal role in the cellular and humoral
immune responses directed against foreign antigens, We characterized t
he in vitro and in vivo properties of a chimeric protein consisting of
mouse IL-2 fused to the mouse IgG2b Fe domains. This fusion protein b
inds to IL-2 and Fc receptors and supports IL-2-dependent cell prolife
ration but does not mediate lysis of IL-2 receptor-positive cells in t
he presence of murine complement in vitro. However, in vivo the IL2-Ig
G2b fusion protein suppresses both cellular and humoral immune respons
es after immunization with sheep erythrocytes, Surprisingly, delayed h
ypersensitivity is inhibited despite a dramatic increase of splenic CD
3+ and NK1.1+ lymphocytes, indicating that altered homing of IL2-IgG2b
-activated lymphocytes rather than cytolysis prevents these cells from
accumulating in areas of inflammation, Although in vitro the IL2-IgG2
b fusion protein does not alter proliferation of B cells in response t
o mitogenic stimulation, IgM production in response to sheep erythrocy
tes is profoundly inhibited in mice treated with the IL2-IgG2b fusion
protein, Since no side effects are observed, the IL2-IgG2b fusion prot
ein may expand the therapeutic repertoire of reagents used for the tre
atment of allograft rejection and autoimmune diseases.